CRMD - CorMedix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRMD is currently covered by 5 analysts with an average price target of $20.47. This is a potential upside of $8.44 (70.16%) from yesterday's end of day stock price of $12.03.

CorMedix's activity chart (see below) currently has 30 price targets and 46 ratings on display. The stock rating distribution of CRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.83% with an average time for these price targets to be met of 318.63 days.

Highest price target for CRMD is $15, Lowest price target is $12, average price target is $14.5.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 09-Apr-2025. First documented stock forecast 12-Dec-2018.

Currently out of the existing stock ratings of CRMD, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$2.62 (27.93%)

$12

1 months ago
(09-Apr-2025)

11/15 (73.33%)

$5 (71.43%)

438

Buy

$15

$5.62 (59.91%)

$15

1 months 1 days ago
(08-Apr-2025)

0/5 (0%)

$8.21 (120.91%)

Buy

$12

$2.62 (27.93%)

$12

1 months 13 days ago
(26-Mar-2025)

4/5 (80%)

$4.84 (67.60%)

203

Buy

1 years 5 months 24 days ago
(15-Nov-2023)

0/1 (0%)

$8.28 (70.65%)

Buy

$19

$9.62 (102.56%)

$16

1 years 11 months 20 days ago
(19-May-2023)

0/9 (0%)

$13.9 (272.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRMD (CorMedix) average time for price targets to be met?

On average it took 318.63 days on average for the stock forecasts to be realized with a an average price target met ratio 35.83

Which analyst has the current highest performing score on CRMD (CorMedix) with a proven track record?

SERGE BELANGER

Which analyst has the current lower performing score on CRMD (CorMedix) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on CRMD (CorMedix)?

Serge Belanger works at NEEDHAM and has 4 price targets and 13 ratings on CRMD

Which analyst is the currently most bullish on CRMD (CorMedix)?

Andrew D'silva with highest potential upside - $20.02

Which analyst is the currently most reserved on CRMD (CorMedix)?

James Lee with lowest potential downside - -$0

CorMedix in the News

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?